Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study [clinicaltrials:NCT00230373]
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study [clinicaltrials:NCT00230373]
Bio2RDF identifier
NCT00230373
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00230373
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Localized scleroderma o ...... treatment period (month 12).
brief title [clinicaltrials_vocabulary:brief-title]
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2007-06-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-28T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Localized scleroderma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-04-22T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00230373
official title [clinicaltrials_vocabulary:official-title]
Evaluation of the Efficacy and ...... , Prospective Open-label Study
org study id [clinicaltrials_vocabulary:org-study-id]
04CA05-IMIQ
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-11-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-04-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Study never started.
identifier
clinicaltrials:NCT00230373
title
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
@en
type
label
Imiquimod 5% Cream in Plaque-t ...... y [clinicaltrials:NCT00230373]
@en